stage III melanoma

0:11:47

What is Stage III Melanoma?

0:03:40

Developments in the Management of Stage III Melanoma

0:01:27

Dr. Olszanski Discusses Advances in Stage III Melanoma

0:01:47

Evaluating the impact of adjuvant therapy on stage III melanoma survival

0:01:08

Treatment options for stage III melanoma patients

0:01:34

Dr. Eggermont on Responses to Adjuvant Pembrolizumab in Stage III Melanoma Subtypes

0:01:22

The personalization of neoadjuvant immunotherapy in stage III melanoma

0:02:05

Dr. Weber on Adjuvant Approaches in Stage III Melanoma

0:02:46

Neoadjuvant therapy in bulky Stage III melanoma

0:05:00

Adjuvant Therapy for Stage III Melanoma

0:26:20

Understanding Lymph Node Dissection and Neoadjuvant Treatment for Stage III Melanoma

0:05:07

Be Your Own Advocate: Morgan England, Stage III Melanoma Survivor, Shares Her Story

0:14:02

Options for Stage II and Stage III Melanoma: Factors When Considering a Plan That Is Right for You

0:12:16

Dr. John Fruehauf on a New Standard of Care for Stage III Melanoma

0:03:02

A New Standard for Stage 3 BRAF+ Melanoma

0:05:51

Alternative Adjuvant Approaches in Stage III Melanoma

0:03:51

Molecular Testing for Stage III Melanoma

0:01:18

Comment: Ipilimumab in high risk stage III melanoma

0:02:00

Dr. Blank on Predictive Biomarkers in Macroscopic Stage III Melanoma

0:01:39

Dr. Blank on Adjuvant Versus Neoadjuvant Approaches in Stage III Melanoma

0:02:24

PRADO: personalized response-driven therapy in resectable stage III melanoma

0:05:18

Neoadjuvant ipilimumab and nivolumab immunotherapy for resectable stage III melanoma

0:01:30

Molecular Testing in Stage 3 Melanoma

0:05:30

Jeffrey S Weber, ASCO 2018 – Resected stage III melanoma and the CheckMate 238 trial